Announcements Trials
Browse Landscape

Status

Completed 30Withdrawn 4Recruiting 3Active not recruiting 3Unknown 2Terminated 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

gallium 68 PSMA-11 2carbon-11 acetate 2Magnetic Resonance Spectroscopy 2radium Ra 223 dichloride 1pegilodecakin 1bicalutamide 1apalutamide 1Suspensions 1Standard of Care 1Sodium Acetate 1Prednisone 1Prednisolone 1Powders 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid 1MLN 8237 1Androgen Antagonists 1Abiraterone Acetate 1AM0010 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Prostatic Neoplasms × radium Ra 223 dichloride × Clear all
NCT01516762 2014-07-14

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Bayer

No longer available
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡